John Raoux / AP
In this July 16, 2012, file photo, Johnson & Johnson products are displayed in Orlando, Fla.
Friday, Nov. 25, 2016 | 12:54 p.m.
NEW YORK — Johnson & Johnson said Friday that is in early talks to buy the Swiss drugmaker Actelion Pharmaceuticals.
Actelion Pharmaceuticals Ltd. makes high blood pressure medicines that treat arteries in the lung and around the heart. Johnson & Johnson of New Brunswick, New Jersey, develops drugs and manufactures medical devices and other consumer products.
Shares of Johnson & Johnson rose $1.06 to $114.13 Friday.
Join the Discussion:
Check this out for a full explanation of our conversion to the LiveFyre commenting system and instructions on how to sign up for an account.
Full comments policy